The Company entered a licensing agreement for a license to use the Cell-in-a-Box^® technology to develop therapies involving Cannabis for a total amount of $2.0 million “Upfront Payment” for the license (see Note 10). As of June 30, 2016, the Company’s license agreement obligation was paid in full.